Dioscin Suppresses Ovarian and Gastric Tumor Progression by Inhibiting ALDH1A3 ‐Mediated Retinoic Acid Metabolism and Cancer Stemness
Phytotherapy Research · 2026
DOI: 10.1002/ptr.70247 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytotherapy Research, 2026. Verfasst von Kang Wu und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Diosgenin, Neoplastic Stem Cells, Tretinoin. Die Arbeit nennt 50 Literaturangaben. Gefördert von: the National Natural Science Foundation of China, the National Administration of Traditional Chinese Medicine Inheritance and Innovation Team Project, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
ALDH1A3 is a key factor associated with tumor stemness and chemotherapy resistance, making it a promising therapeutic target. Screening various compounds with potential inhibition of cancer stem cells led to the discovery of a naturally occurring Dioscin as a novel ALDH1A3 inhibitor. However, the precise mechanism underlying its action remains unexplored. Experimental Procedure Immunohistochemical analysis of 90 ovarian serous tumor samples revealed the clinical significance of ALDH1A3 in tumor progression. TCGA data was used to identify genes highly correlated with ALDH1A3 in ovarian cancer. Using CRISPR/Cas9‐generated ALDH1A3 knockout (KO) cell lines, we investigated its oncogenic influence in ovarian and gastric cancers. The anti‐tumor effects of Dioscin were assessed through MTT, scratch, and 3D spheroid formation assays. In vivo efficacy of Dioscin was assessed using a xenograft mouse model. Mechanistic investigations of Dioscin with ALDH1A3 were predicted by molecular docking and assessed through ALDH1A3 enzymatic activity and retinoic acid (RA) metabolism analyses.
Results
ALDH1A3 expression correlates with early‐stage ovarian cancer progression. Genetic ablation of ALDH1A3 significantly suppressed cell proliferation, migration, and stemness properties. ALDH1A3 is significantly associated with ECM‐related genes in ovarian cancer. Dioscin exhibited an ALDH1A3‐dependent anti‐tumor effect by inhibiting ALDH1A3 enzymatic activity, disrupting RA metabolism, and downregulating the expression of stemness‐ and migration‐associated proteins (CD44 and MMP2). Furthermore, Dioscin effectively delays tumor growth without obvious signs of toxicity.
Conclusion
Our study provides the first evidence that Dioscin inhibits ALDH1A3‐mediated RA metabolism and cancer stemness. Our data will further support its potential as a therapeutic agent for cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China.
- Department of Pathology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University. Beijing Maternal and Child Health Care Hospital, Beijing, China.
- Department of Medicinal Chemistry, College of Pharmacy, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA.
- Department of Clinical Medicine, Yanjing Medical College, Capital Medical University, Beijing, China.
ORCID-Profile: Nouri Neamati
Förderung
- the National Natural Science Foundation of China
- the National Administration of Traditional Chinese Medicine Inheritance and Innovation Team Project
- National Natural Science Foundation of China
Zitieren
APA
Wu, K., Wang, Z., Zheng, X., Neamati, N., Qiu, C., Zheng, J., Ma, J., Yu, H., Ma, Q., Tian, J., & Lu, T. (2026). Dioscin Suppresses Ovarian and Gastric Tumor Progression by Inhibiting ALDH1A3 ‐Mediated Retinoic Acid Metabolism and Cancer Stemness. Phytotherapy Research. https://doi.org/10.1002/ptr.70247
Vancouver
Wu K, Wang Z, Zheng X, Neamati N, Qiu C, Zheng J, et al. Dioscin Suppresses Ovarian and Gastric Tumor Progression by Inhibiting ALDH1A3 ‐Mediated Retinoic Acid Metabolism and Cancer Stemness. Phytotherapy Research. 2026. doi:10.1002/ptr.70247
BibTeX
@article{Wu2026,
author = {Wu, Kang and Wang, Ziying and Zheng, Xingzheng and Neamati, Nouri and Qiu, Chentao and Zheng, Jiaying and Ma, Jianhui and Yu, Haiyun and Ma, Qihong and Tian, Jiawei and Lu, Tiangong},
title = {Dioscin Suppresses Ovarian and Gastric Tumor Progression by Inhibiting ALDH1A3 ‐Mediated Retinoic Acid Metabolism and Cancer Stemness},
journal = {Phytotherapy Research},
year = {2026},
doi = {10.1002/ptr.70247}
}
EUVIMED